Brief: Bioservo Technologies Q4 EBITDA Loss Widens To SEK 15.5 Mln
Feb 22 (Reuters) - Bioservo Technologies AB BIOSE.ST :
* BIOSERVO TECHNOLOGIES AB YEAR-END REPORT 2022
* Q4 NET SALES OF SEK 1.3 M (2.3)
* Q4 EBITDA OF SEK -15.5 M (-7.5)
Source text for Eikon: ID:nWkr8K5PNF
Further company coverage: BIOSE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))